Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-01 00:00 |
Fagron press release H1 2024_Eng.pdf
|
English | 330.4 KB | ||
| 2024-08-01 00:00 |
Fagron press release H1 2024_NL.pdf
|
Dutch | 876.1 KB | ||
| 2024-05-14 07:43 |
Fagron shareholders approve all voting items at AGM and EGM
|
English | 99.4 KB | ||
| 2024-05-14 07:43 |
Fagron shareholders approve all voting items at AGM and EGM
|
Dutch | 104.5 KB | ||
| 2024-04-12 08:24 |
Fagron publiceert agenda jaarlijkse en buitengewone aandeelhoudersvergadering 2…
|
English | 93.5 KB | ||
| 2024-04-12 08:24 |
Fagron publiceert agenda jaarlijkse en buitengewone aandeelhoudersvergadering 2…
|
Dutch | 98.1 KB | ||
| 2024-04-12 08:00 |
1 - Convocation AGM and EGM 13 May 2024.pdf
|
English | 1.9 MB | ||
| 2024-04-12 08:00 |
1 - Oproeping AVA en BAV 13 mei 2024.pdf
|
Dutch | 2.1 MB | ||
| 2024-04-12 08:00 |
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary …
|
English | 93.5 KB | ||
| 2024-04-12 08:00 |
Fagron publiceert agenda jaarlijkse en buitengewone aandeelhoudersvergadering 2…
|
Dutch | 98.1 KB | ||
| 2024-04-11 07:36 |
Record revenue of €209 million in first quarter reflecting 15% topline growth
|
Dutch | 224.6 KB | ||
| 2024-04-11 07:36 |
Record revenue of €209 million in first quarter reflecting 15% topline growth
|
English | 221.1 KB | ||
| 2024-04-11 07:00 |
Record revenue of €209 million in first quarter reflecting 15% topline growth.p…
|
English | 221.1 KB | ||
| 2024-04-11 07:00 |
Recordomzet van €209 miljoen in eerste kwartaal en 15% omzetgroei.pdf
|
Dutch | 224.6 KB | ||
| 2024-03-20 08:27 |
Disclosure notification from Mawer Investment Management Ltd.
|
Dutch | 99.0 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |